Haemophilus ducreyi is susceptible to protegrin

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 10, 1998, Pages 2690-2693

  Fortney, Kate ^a   Totten, Patricia A ^b   Lehrer, Robert I ^c   Spinola, Stanley M ^a  

^a INDIANA UNIVERSITY   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; PROTEGRIN 1; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERICIDAL ACTIVITY; COLONY FORMING UNIT; CONTROLLED STUDY; HAEMOPHILUS DUCREYI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RIBOTYPING; SEXUALLY TRANSMITTED DISEASE; ULCUS MOLLE;

EID: 0031657736     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.10.2690     Document Type: Article

References (25)

1. Behets, F. M. T., G. Liomba, G. Lule, G. Dallabetta, I. F. Hoffman, H. A. Hamilton, S. Moeng, and M. S. Cohen. 1995. Sexually transmitted diseases and human immunodefiency virus control in Malawi: a field study of genital ulcer disease. J. Infect. Dis. 171:451-455.
2. Dangor, Y., R. C. Ballard, S. D. Miller, and H. J. Koornhof. 1990. Antimicrobial susceptibility of Haemophilus ducreyi. Antimicrob. Agents. Chemother. 34:1303-1307.
3. Gibson, B. W., A. A. Campagnari, W. Melaugh, N. J. Phillips, M. A. Apicella, S. Grass, J. Wang, K. L. Palmer, and R. S. Munson, Jr. 1997. Characterization of transposon Tn916-generated mutant of Haemophilus ducreyi 35000 defective in lipooligosaccharide biosynthesis. J. Bacteriol. 179:5062-5071.
4. Harwig, S. S. L., A. Waring, H. J. Yang, Y. Cho, L. Tan, and R. I. Lehrer. 1996. Intramolecular disulfide bonds enhance the antimicrobial and lytic activities of protegrins at physiological sodium chloride concentrations. Eur. J. Biochem. 240:352-357.
5. Kilian, M., and J. Theilade. 1975. Cell wall ultrastructure of strain of Haemophilus ducreyi and Haemophilus piscium. Int. J. Syst. Bacteriol. 25:351-356.
6. Knapp. J. S., A. F. Back, A. F. Babst, D. Taylor, and R. J. Rice. 1993. In vitro susceptibles of isolates of Haemophilus ducreyi from Thailand and the United States to currently recommended and newer agents for treatment of chancroid. Antimicrob. Agents Chemother. 37:1552-1555.
7. Kokryakov, V. N., S. S. L. Harwig, E. A. Panyutich, A. A. Schevchenko, G. M. Aleshina, O. V. Shamova, H. A. Korneva, and R. I. Lehrer. 1993. Protegrins: leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins. FEBS. Lett. 327:231-236.
8. Lehrer, R. I., M. Rosenman, S. S. L. Harwig, R. Jackson, and P. Eisenhauser. 1991. Ultrasensitive assays for endogenous antimicrobial polypeptides. J. Immunol. Methods 137:167-173.
9. Melaugh, W., A. A. Campagnari, and B. W. Gibson. 1996. The lipooligosaccharides of Haemophilus ducreyi are highly sialylated. J. Bacteriol. 178:564-570.
10. Morse, S. A. 1989. Chancroid and Haemophilus ducreyi. Clin. Microbiol. Rev. 2:137-157.
11. Qu, X.-D., S. S. L. Harwig, A. Oren, W. M. Shafer, and R. I. Lehrer. 1996. Susceptibility of Neisseria gonorrhoeae to protegrins. Infect. Immun. 64:1240-1245.
12. Qu, X.-D., S. S. L. Harwig, W. M. Shafer, and R. I. Lehrer. 1997. Protegrin structure and activity against Neisseria gonorrhoeae. Infecf. Immun. 65:636-639.
13. Sarafian, S. K., T. C. Woods, J. S. Knapp, B. Swaminathan, and S. A. Morse. 1991. Molecular characterization of Haemophilus ducreyi by ribosomal DNA fingerprinting. J. Clin. Microbiol. 29:1949-1954.
14. Schweda, E. K. H., J. A. Jonasson, and P.-E. Jansson. 1995. Structural studies of lipooligosaccharides from Haemophilus ducreyi ITM 5535, ITM 3147, and a fresh clinical isolate. ACY1: evidence for intrastrain heterogeneity with the production of mutually exclusive sialylated or elongated glycoforms. J. Bacteriol. 177:5316-5321.
15. Spinola, S. M., A. Orazi, J. N. Arno, K. Fortney, P. Kotylo, C.-Y. Chen, A. A. Campagnari, and A. F. Hood. 1996. Haemophilus ducreyi elicits a cutaneous infiltrate of CD4 cells during experimental human infection. J. Infect. Dis. 173:344-402.
16. Steinberg, D. A., and R. I. Lehrer. 1997. Designer assays for antimicrobial peptides. Disputing the "one-size-fits-all" theory. Methods Mol. Biol. 78: 169-186.
17. Tamamura, H., T. Murakami, S. Horiuchi, K. Sugihara, A. Otaka, W. Takada, T. Ibuka, M. Waki, N. Yamamuto, and N. Fujii. 1995. Synthesis of protegrin-related peptides and their antibacterial and anti-human immunodeficiency virus activity. Chem. Pharm. Bull. (Tokyo) 43:853-858.
18. Telzak, E. E., M. A. Chiasson, P. J. Bevier, R. L. Stoneburner, K. G. Castro, and H. W. Jaffe. 1993. HIV-1 seroconversion in patients with and without genital ulcer disease. Ann. Intern. Med. 119:1181-1186.
19. Totten, P. A., and W. E. Stamm. 1994. Clear broth and plate media for culture of Haemophilus ducreyi. J. Clin. Microbiol. 32:2019-2023.
20. Trees, D. L., and S. A. Morse. 1995. Chancroid and Haemophilus ducreyi: an update. Clin. Microbiol. Rev. 8:357-375.
21. Wasserheit, J. N. 1992. Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex. Transm. Dis. 19:61-77.
22. Yasin, B., S. S. L. Harwig, R. I. Lehrer, and E. A. Wager. 1996. Susceptibility of Chlamydia trachomatis to protegrins and defensins. Infect. Immun. 64: 709-713.
23. Yasin, B., R. I. Lehrer, S. S. L. Harwig, and E. A. Wagar. 1996. Protegrins: structural requirments for inactivating elementary bodies of Chlamydia trachomatis. Infect. Immun. 64:4863-4866.
24. Zhao, C., T. Ganz, and R. I. Lehrer. 1995. The structure of porcine protegrin genes. FEBS Lett. 368:197-202.
25. Zhao, C., L. Liu, and R. I. Lehrer. 1994. Identification of a new member of the protegrin family by cDNA cloning FEBS Lett. 346:285-288.